12/5
06:30 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Craig Hallum to a "strong-buy" rating.
Low
Report
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Craig Hallum to a "strong-buy" rating.
12/5
06:30 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Craig Hallum to a "strong-buy" rating.
Low
Report
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Craig Hallum to a "strong-buy" rating.
12/3
08:38 am
dsgn
Rating for DSGN
Medium
Report
Rating for DSGN
12/3
08:05 am
dsgn
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Medium
Report
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
12/3
08:05 am
dsgn
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Medium
Report
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
12/3
07:38 am
dsgn
Design Therapeutics initiated with a Buy at Craig-Hallum
Medium
Report
Design Therapeutics initiated with a Buy at Craig-Hallum
12/3
07:38 am
dsgn
Design Therapeutics initiated with a Buy at Craig-Hallum
Medium
Report
Design Therapeutics initiated with a Buy at Craig-Hallum
12/3
06:33 am
dsgn
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
Medium
Report
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
12/3
06:11 am
dsgn
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
Medium
Report
Design Therapeutics upgraded to Outperform from Market Perform at Leerink
11/20
09:55 am
dsgn
Rating for DSGN
Medium
Report
Rating for DSGN
11/20
09:55 am
dsgn
Rating for DSGN
Medium
Report
Rating for DSGN
11/20
08:01 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $13.00 price target on the stock.
Medium
Report
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $13.00 price target on the stock.
11/20
08:01 am
dsgn
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $13.00 price target on the stock.
Medium
Report
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $13.00 price target on the stock.
11/20
05:04 am
dsgn
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Medium
Report
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
11/20
05:04 am
dsgn
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Medium
Report
Design Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
11/6
10:47 am
dsgn
Rating for DSGN
Medium
Report
Rating for DSGN
11/6
10:47 am
dsgn
Rating for DSGN
Medium
Report
Rating for DSGN